POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients

Anthracyclines are among the most used chemotherapeutic agents in breast cancer (BC). However their use is hampered by anthracycline-induced cardiotoxicity (AIC). The currently known clinical and genetic risk factors do not fully explain the observed inter-individual variability and only have a limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Velasco-Ruiz, Alejandro, Nuñez-Torres, Rocio, Pita, Guillermo, Wildiers, Hans, Lambrechts, Diether, Hatse, Sigrid, Delombaerde, Danielle, Van Brussel, Thomas, Alonso, M. Rosario, Alvarez, Nuria, Herraez, Belen, Vulsteke, Christof, Zamora, Pilar, Lopez-Fernandez, Teresa, Gonzalez-Neira, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622627/
https://www.ncbi.nlm.nih.gov/pubmed/34834357
http://dx.doi.org/10.3390/pharmaceutics13111942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622627/
https://www.ncbi.nlm.nih.gov/pubmed/34834357
http://dx.doi.org/10.3390/pharmaceutics13111942

Ejemplares similares